This paper was interesting, first, because we had a lecture on psychoimmunology last week. Basic knowledge on neuroimmune system made this paper more comprehensible, and seeing actual images of structures covered in the lecture – including ratified and amoeboid forms of microglia – and quantifiable measurements that go along with the images improved my understanding of microglia.
One of the main things that I found odd was the use of male rodents and male rodents only. Most of the papers that I have encountered included both sexes of the animals that are part of the studied and often included analysis of the data related to sex differences. Because the paper’s hypothesis does not state that they this study focuses on the involvement of microglial alterations in development of neurogenesis suppression and depression in males specifically, the study should have included the female rodents.
Another point I was curious about was the accuracy of taking the average consumption of medication. In the experiment involving administration of imipramine and minocycline, the paper states that the doses of the medication consumed by the subjects were an average of two to three animals housed in a same cage. Taking the average instead of measuring individual intake of the medication could have altered the results of the data; for example, if animals Z – in a cage of three animals – did not drink as much water/medication as the other two, the dose of the medication that the animal Z would have been overestimated in the graph since the average of the three animals is higher than what the animal actually consumed.
For behavioral study, the researchers focused on three main observations: social exploration, forced swim/floating time, and sucrose preference. Because the previous paper that I read about depressive-like behavior included only one behavioral study (forced swim test), I found this paper much more trust-worthy and valid with three different behavioral tests used to study depressive-like behavior.
Regarding the data, some of the data/graphs that were in the paper seemed a bit odd. For example, in Figure 3f and 3l, the paper claims that there are no significant differences between the control and CUS subjects in the medication-treated group. However, the data seem to have a significant difference. Although there probably are valid reasons that can explain why there were no significant differences, because not having a statistically significant difference in those two graphs support the study’s hypothesis, it could be that researcher was slightly lenient with the data analysis.
Lastly, not having a background knowledge of about behavioral genetics, it was quite difficult to understand the tests involving different mRNA expressions and neuronal markers. Because the study does focus a significant amount of analysis on the genetic studies, the paper would been even better with higher understanding of behavioral genetics.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.